Search at Vanderbilt-Ingram Cancer Center

1144 results found

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Relevance: 1

Cryodevitalization for the Treatment of Early Stage Lung Cancer, CRYSTAL Trial

Relevance: 1

Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer

Relevance: 1

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

Relevance: 1

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

Relevance: 1

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Relevance: 1

Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy

Relevance: 1

A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia

Relevance: 1

A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor

Relevance: 1

Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer

Relevance: 1